Open access peer-reviewed chapter

Mitral Valve Insufficiency, a Constituent of Left Atrial Myxoma: Pathobiology, Physiopathology, and Pathophysiology of Left Atrial Myxoma; Are Long-Term Results Still Feasible?

By Iroegbu Chukwuemeka Daniel, Zhongxin Zhou, Zhang Hao and Jindong Liu

Submitted: December 6th 2017Reviewed: March 15th 2018Published: October 3rd 2018

DOI: 10.5772/intechopen.76510

Downloaded: 161

© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Iroegbu Chukwuemeka Daniel, Zhongxin Zhou, Zhang Hao and Jindong Liu (October 3rd 2018). Mitral Valve Insufficiency, a Constituent of Left Atrial Myxoma: Pathobiology, Physiopathology, and Pathophysiology of Left Atrial Myxoma; Are Long-Term Results Still Feasible?, Structural Insufficiency Anomalies in Cardiac Valves, Kaan Kirali, IntechOpen, DOI: 10.5772/intechopen.76510. Available from:

chapter statistics

161total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Cardiac Dyssynchrony as a Pathophysiologic Factor of Functional Mitral Regurgitation: Role of Cardiac Resynchronization Therapy

By Barbara Brzezińska and Krystyna Łoboz-Grudzień

Related Book

First chapter

Introductory Chapter: Last Crossroad

By Kaan Kırali

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More about us